Profil
Ya Jin Ni worked as Director-Developmental Sciences at VIRxSYS Corp., Head-Process Development at Pfizer Inc. and Allogene Therapeutics, Inc. She also served as Chief Technology Officer at Gracell Biotechnologies, Inc. from 2021 to 2023.
Dr. Ni holds a doctorate degree from Kyoto University and Kunming Medical University.
Anciens postes connus de Jenny Ni
| Sociétés | Poste | Fin |
|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Directeur Technique/Scientifique/R&D | 07/04/2023 |
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Formation de Jenny Ni
| Kyoto University | Doctorate Degree |
| Kunming Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
